All In MedTech

Device Trial Radar · NCT02143778

Assessing Portal Hypertension With Methacetin Breath Test

Clinical Study of the BreathID® LF System to Train the Algorithm for the ¹³C-Methacetin Breath Test (MBT) in Assessment of Portal Hypertension in Patients With Compensated Liver Cirrhosis

Last checked: Nov 20, 2026Latest source record: Dec 20, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

246

Actual

Start

Nov 2014

Primary completion

Dec 2018

Study completion Jan 2019

Sponsor

Lead sponsor
Meridian Bioscience, Inc.Not on our public-company list
Sponsor type
Industry
First posted
May 21, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will be used to train an algorithm using Methacetin breath test (MBT) measures and to select a cut-off to determine presence or absence of Clinically Significant Portal Hypertension (CSPH) as defined by Hepatic Venous Gradient Pressure (HVPG) ≥ 10mmHg,

Conditions

  • Patients With Compensated Liver Cirrhosis

Interventions

  • Methacetin Breath TestDevice

    13C labelled methacetin solution for breath test monitoring

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. CSPH (Clinically Significant Portal Hypertension)Time frame: 1 hour

Locations

8 sites in 4 countries. Site status is shown where the registry gives one.

  • VA Connecticut HealthCare System

    New Haven, Connecticut

  • Duke University Medical Center

    Durham, North Carolina

  • Virginia Commonwealth University

    Richmond, Virginia

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.